SpyGlass Pharma, Inc.

Market Cap

$612M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$18.78-$7.62 (-28.86%)

Jun 5, 2026

52W High $29.6852W Low $18.32

Company Details

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including no...

CEO

—

IPO Date

Feb 6, 2026

Website

www.spyglasspharma.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$44M

EPS (Diluted)

Free Cash Flow

-$39M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 13, 2026

PENDING

Q1 2026

May 14, 2026

FY 2025

Mar 27, 2026

Q4 2025

Mar 27, 2026

Q1 2025

Mar 31, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee